Chemoinformaics analysis of 1,1-Diethoxy-3-methylbutane
| Molecular Weight | 160.257 | nRot | 6 |
| Heavy Atom Molecular Weight | 140.097 | nRig | 2 |
| Exact Molecular Weight | 160.146 | nRing | 0 |
| Solubility: LogS | -2.185 | nHRing | 0 |
| Solubility: LogP | 2.621 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 29.9699 |
| nHD | 0 | BPOL | 23.5361 |
| QED | 0.424 |
| Synth | 2.501 |
| Natural Product Likeliness | 1.639 |
| NR-PPAR-gamma | 0.013 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.012 |
| HIA | 0.007 |
| CACO-2 | -4.324 |
| MDCK | 0.0000276 |
| BBB | 0.995 |
| PPB | 0.836713 |
| VDSS | 0.618 |
| FU | 0.218072 |
| CYP1A2-inh | 0.848 |
| CYP1A2-sub | 0.784 |
| CYP2c19-inh | 0.324 |
| CYP2c19-sub | 0.638 |
| CYP2c9-inh | 0.141 |
| CYP2c9-sub | 0.907 |
| CYP2d6-inh | 0.017 |
| CYP2d6-sub | 0.743 |
| CYP3a4-inh | 0.054 |
| CYP3a4-sub | 0.159 |
| CL | 9.588 |
| T12 | 0.813 |
| hERG | 0.019 |
| Ames | 0.007 |
| ROA | 0.021 |
| SkinSen | 0.805 |
| Carcinogencity | 0.549 |
| EI | 0.989 |
| Respiratory | 0.027 |
| NR-Aromatase | 0.007 |
| Antiviral | No |
| Prediction | 0.92495 |